Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Afonso, K. Verhamme, G. Brusselle, M. Sturkenboom (Rotterdam, Netherlands; Ghent, Belgium). β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD. Eur Respir J 2011; 38: Suppl. 55, 3359

Member's Comments

No comment yet.

Related content which might interest you: Predictors of exacerbations requiring hospitalisation in patients with stable COPD Source: Eur Respir J 2006; 28: Suppl. 50, 177s Year: 2006 Predictors of mortality in COPD patients after hospitalization due to an exacerbation Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Risk factors for another hospitalization in COPD patients hospitalized for exacerbation Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Rehospitalizations for an acute exacerbation among patients with COPD Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Characterization of readmissions in patients hospitalized with COPD exacerbation Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Predicting mortality in patients hospitalised with acute exacerbations of COPD (AECOPD) requiring assisted ventilation Source: Annual Congress 2012 - New scientific findings on noninvasive ventilation in the acute setting Year: 2012 COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Statins and outcome of COPD patients after hospitalization for COPD exacerbations Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010 In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality Source: International Congress 2015 – COPD: interesting notes Year: 2015 Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 COPD mortality after severe exacerbations Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020 Polypharmacy in patients hospitalised for acute exacerbation of COPD Source: Eur Respir J 2014; 44: 791-794 Year: 2014 COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis Source: International Congress 2016 – Dealing with the complexity of critically-ill patients Year: 2016 Trends in the lifetime risk of COPD exacerbation requiring hospitalisation Source: Eur Respir J 2013; 42: 964-971 Year: 2013 Risk factors for hospitalization of an acute exacerbation of COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 177s Year: 2006 The relation of comorbidities with the exacerbation severity in patients with COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 High-risk patients following hospitalisation for an acute exacerbation of COPD Source: Eur Respir J 2013; 42: 946-955 Year: 2013 The risk of hyperkalemia in COPD and asthma patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 The main reasons of exacerbation and hospitalization of COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 558s Year: 2007 Polypharmacy in patients with acute exacerbation of COPD Source: Annual Congress 2011 - COPD management Year: 2011